Proton beam irradiation for treatment of experimental human retinoblastoma.

P. P. Svitra, D. Budenz, Daniel Albert, A. M. Koehler, E. Gragoudas

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Proton beam irradiation was used to treat human retinoblastoma (Y-79 cell line) grown subcutaneously in the athymic "nude" mouse. Thirty-four tumors were included in the experimental groups, of which twenty-three were irradiated and eleven served as controls. Tumors were irradiated with protons produced at the 160 megavolts Harvard cyclotron. The dose delivered to the tumor ranged from 7.5 to 27.5 proton gray in a single treatment, and 25.0 proton gray delivered in two fractions separated by 24 hours. Reduction of tumor growth was significantly greater than controls (p less than 0.001) with treatment doses greater than or equal to 17.5 proton gray. Histologic examination revealed a marked decrease of mitotic activity in all specimens examined 48 hours after treatment at these higher doses. Total regression without evidence of remaining malignant cells was noted in three tumors treated at 17.5 proton gray or above. Our results indicate that human retinoblastoma in a murine host, with a tumor mass similar to that seen in a clinical setting, is sensitive to radiation by high energy protons.

Original languageEnglish (US)
Pages (from-to)57-62
Number of pages6
JournalEuropean journal of ophthalmology
Volume1
Issue number2
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Retinoblastoma
Protons
Neoplasms
Nude Mice
Cyclotrons
Radiation
Cell Line
Growth

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Svitra, P. P., Budenz, D., Albert, D., Koehler, A. M., & Gragoudas, E. (1991). Proton beam irradiation for treatment of experimental human retinoblastoma. European journal of ophthalmology, 1(2), 57-62.

Proton beam irradiation for treatment of experimental human retinoblastoma. / Svitra, P. P.; Budenz, D.; Albert, Daniel; Koehler, A. M.; Gragoudas, E.

In: European journal of ophthalmology, Vol. 1, No. 2, 01.01.1991, p. 57-62.

Research output: Contribution to journalArticle

Svitra, PP, Budenz, D, Albert, D, Koehler, AM & Gragoudas, E 1991, 'Proton beam irradiation for treatment of experimental human retinoblastoma.', European journal of ophthalmology, vol. 1, no. 2, pp. 57-62.
Svitra, P. P. ; Budenz, D. ; Albert, Daniel ; Koehler, A. M. ; Gragoudas, E. / Proton beam irradiation for treatment of experimental human retinoblastoma. In: European journal of ophthalmology. 1991 ; Vol. 1, No. 2. pp. 57-62.
@article{c042b9802b2e408b92220bf4c3dd9c89,
title = "Proton beam irradiation for treatment of experimental human retinoblastoma.",
abstract = "Proton beam irradiation was used to treat human retinoblastoma (Y-79 cell line) grown subcutaneously in the athymic {"}nude{"} mouse. Thirty-four tumors were included in the experimental groups, of which twenty-three were irradiated and eleven served as controls. Tumors were irradiated with protons produced at the 160 megavolts Harvard cyclotron. The dose delivered to the tumor ranged from 7.5 to 27.5 proton gray in a single treatment, and 25.0 proton gray delivered in two fractions separated by 24 hours. Reduction of tumor growth was significantly greater than controls (p less than 0.001) with treatment doses greater than or equal to 17.5 proton gray. Histologic examination revealed a marked decrease of mitotic activity in all specimens examined 48 hours after treatment at these higher doses. Total regression without evidence of remaining malignant cells was noted in three tumors treated at 17.5 proton gray or above. Our results indicate that human retinoblastoma in a murine host, with a tumor mass similar to that seen in a clinical setting, is sensitive to radiation by high energy protons.",
author = "Svitra, {P. P.} and D. Budenz and Daniel Albert and Koehler, {A. M.} and E. Gragoudas",
year = "1991",
month = "1",
day = "1",
language = "English (US)",
volume = "1",
pages = "57--62",
journal = "European Journal of Ophthalmology",
issn = "1120-6721",
publisher = "Wichtig Publishing",
number = "2",

}

TY - JOUR

T1 - Proton beam irradiation for treatment of experimental human retinoblastoma.

AU - Svitra, P. P.

AU - Budenz, D.

AU - Albert, Daniel

AU - Koehler, A. M.

AU - Gragoudas, E.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Proton beam irradiation was used to treat human retinoblastoma (Y-79 cell line) grown subcutaneously in the athymic "nude" mouse. Thirty-four tumors were included in the experimental groups, of which twenty-three were irradiated and eleven served as controls. Tumors were irradiated with protons produced at the 160 megavolts Harvard cyclotron. The dose delivered to the tumor ranged from 7.5 to 27.5 proton gray in a single treatment, and 25.0 proton gray delivered in two fractions separated by 24 hours. Reduction of tumor growth was significantly greater than controls (p less than 0.001) with treatment doses greater than or equal to 17.5 proton gray. Histologic examination revealed a marked decrease of mitotic activity in all specimens examined 48 hours after treatment at these higher doses. Total regression without evidence of remaining malignant cells was noted in three tumors treated at 17.5 proton gray or above. Our results indicate that human retinoblastoma in a murine host, with a tumor mass similar to that seen in a clinical setting, is sensitive to radiation by high energy protons.

AB - Proton beam irradiation was used to treat human retinoblastoma (Y-79 cell line) grown subcutaneously in the athymic "nude" mouse. Thirty-four tumors were included in the experimental groups, of which twenty-three were irradiated and eleven served as controls. Tumors were irradiated with protons produced at the 160 megavolts Harvard cyclotron. The dose delivered to the tumor ranged from 7.5 to 27.5 proton gray in a single treatment, and 25.0 proton gray delivered in two fractions separated by 24 hours. Reduction of tumor growth was significantly greater than controls (p less than 0.001) with treatment doses greater than or equal to 17.5 proton gray. Histologic examination revealed a marked decrease of mitotic activity in all specimens examined 48 hours after treatment at these higher doses. Total regression without evidence of remaining malignant cells was noted in three tumors treated at 17.5 proton gray or above. Our results indicate that human retinoblastoma in a murine host, with a tumor mass similar to that seen in a clinical setting, is sensitive to radiation by high energy protons.

UR - http://www.scopus.com/inward/record.url?scp=0026134779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026134779&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 57

EP - 62

JO - European Journal of Ophthalmology

JF - European Journal of Ophthalmology

SN - 1120-6721

IS - 2

ER -